SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 7,656.11 |
| Enterprise Value ($M) | 6,770.74 |
| Book Value ($M) | 777.15 |
| Book Value / Share | 35.63 |
| Price / Book | 9.85 |
| NCAV ($M) | 767.56 |
| NCAV / Share | 35.19 |
| Price / NCAV | 9.97 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.58 |
| Return on Assets (ROA) | -0.81 |
| Return on Equity (ROE) | -1.28 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.93 |
| Current Ratio | 5.98 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,063.67 |
| Assets | 1,073.27 |
| Liabilities | 296.11 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Janus Henderson Group Plc | |||
| 13G | Rtw Investments, Lp | 9.20 | ||
| 13G/A | Paulson & Co. Inc. | 9.40 | 84.67 | |
| 13D/A | Baker Bros. Advisors Lp | 9.99 | 4.17 | |
| 13G/A | Armistice Capital, Llc | 0.25 | -75.96 | |
| 13G/A | Avoro Capital Advisors LLC | 9.90 | 37.88 | |
| 13G/A | Vanguard Group Inc | 7.98 | 24.35 | |
| 13G/A | BlackRock, Inc. | 6.10 | 22.91 | |
| 13G/A | State Street Corp | 3.55 | -44.43 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 43,295 | 225,241 | 19.22 | |
| 51,623 | 186,386 | 27.70 | |
| 45,088 | 216,162 | 20.86 | |
| 26,306 | 133,089 | 19.77 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| LXRX – Lexicon Pharmaceuticals, Inc. | LYEL – Lyell Immunopharma, Inc. |
| MCRB – Seres Therapeutics, Inc. | MGNX – MacroGenics, Inc. |
| MGTX – MeiraGTx Holdings plc |
Financial data and stock pages provided by
Fintel.io